Skip to main content
Log in

Movement disorders induced in monkeys by chronic haloperidol treatment

  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

After several months of treatment, Cebus apella, Cebus albifrons, and Saimiri sciurea monkeys maintained on haloperidol, in doses of 0.5 or 1.0 mg/kg orally 5 days per week, began to display severe movement disorders, typically 1–6 h post-drug. Cebus monkeys exhibited violent, uncontrolled movements that flung the animals about the cage. Such episodes usually lasted only a few minutes, recurring several times during the period following drug ingestion. Writhing and bizarre postures dominated the response in S. sciurea. Cessation of drug treatment produced no distinctive after-effects. When tested as long as 508 days after the last administration, however, Cebus monkeys responded to haloperidol with several episodes of hyperkinesis, even at challenge doses considerably lower than those in the original treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Crane, G. E.: Clinical psychopharmacology in its 20th year. Science 181, 124–128 (1973)

    Google Scholar 

  • Crane, G., Garner, R. Jr. (eds.): Psychotropic drugs and dysfunctions of the basal ganglia, a multidisciplinary workshop. Washington, D.C.: U. S. Government Printing Office 1969

    Google Scholar 

  • Deneau, G. A., Crane, G. E.: Dyskinesia in rhesus monkeys tested with high doses of chlorpromazine. In: Psychotropic drugs and dysfunctions of the basal ganglia, a multidisciplinary workshop, G. E. Crane, R. Gardner Jr., eds., pp. 12–14. Washington, D.C.: U.S. Government Printing Office 1969

    Google Scholar 

  • Deuel, R. K.: Neurological examination of rhesus monkeys treated with high doses of chlorpromazine. In: Psychotropic drugs and dysfunctions of the basal ganglia, a multidisciplinary workshop, G. E., Crane, R. Gardner, Jr., eds., pp. 15–18. Washington, D.C.: U.S. Government Printing Office 1969

    Google Scholar 

  • DiMascio, A. Shader, R. S. (eds.): Butyrophenones in psychiatry. New York: Raven Press 1972

    Google Scholar 

  • Eibergen, R. D., Carlson, K. R.: Dyskinesias in monkeys: Interaction of methamphetamine with prior methadone treatment. Pharmac. Biochem. Behav. 5, 175–187 (1976)

    Google Scholar 

  • Freedman, D. X.: Neurological syndrome associated with antipsychotic drug use: A special editorial report. Arch. gen. Psychiat. 28, 463–467 (1973)

    Google Scholar 

  • Garman, R. H., Weiss, B., Evans, H. L.: Alkylmercurial encephalopathy in the monkey. Acta Neuropathologica 32, 61–74 (1975)

    Google Scholar 

  • Grabowski, S. W.: Haloperidol for control of severe emotional reactions in mentally retarded patients. Dis. nerv. Syst. 34, 315–317 (1973)

    Google Scholar 

  • Gunne, L.-M., Bárány, S.: Haloperidol-induced tardive dyskinesia in monkeys. Psychopharmacology 50, 237–240 (1976)

    Google Scholar 

  • Jacobson, G., Baldessarini, R. J., Manschreck, T.: Tardive and withdrawal dyskinesia associated with haloperidol. Amer. J. Psychiat. 131, 910–913 (1974)

    Google Scholar 

  • Man, P. L.: Long-term effects of haloperidol. Dis. nerv. Syst. 34, 113–118 (1973)

    Google Scholar 

  • Ordy, J. M., Samorajsky, T., Schroeder, D. M.: Haloperidol and electric shock interaction effects on tremors and on catecholamine concentrations in the caudate nucleus of the squirrel monkey. Brain Research 12, 427–436 (1969)

    Google Scholar 

  • Paulson, G. W.: Dyskinesia in monkeys. In: Advances in neurology, vol. I, A. Barbeau, T. N. Chase, G. W. Paulson, eds., pp. 647–650. New York: Raven Press 1973

    Google Scholar 

  • Sassin, J. F.: Drug-induced dyskinesia in monkeys. In: Advances in neurology, vol. 10, B. S. Meldrum and C. D. Marsden, eds., pp. 47–54. New York: Raven Press 1975

    Google Scholar 

  • Shader, R. I.: Extrapyramidal and cardiovascular side effects of butyrophenones. In: Butyrophenones in psychiatry, A. DiMascio and R. I. Shader, eds., pp. 97–114 (Ch. 7). New York: Raven Press 1972

    Google Scholar 

  • Weiss, B.: Long-term behavioral consequences of exposure to drugs and pollutants. In: Alcohol, drugs and brain damage, J. G. Rankin, ed., pp. 71–79. Toronto: Addiction Research Foundation of Ontario 1975

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weiss, B., Santelli, S. & Lusink, G. Movement disorders induced in monkeys by chronic haloperidol treatment. Psychopharmacology 53, 289–293 (1977). https://doi.org/10.1007/BF00492366

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00492366

Key words

Navigation